Sunshine Biopharma Inc. -27SBFMWPreferred / convertible
13F holders, Q3 2025 (September 30)3holders
0new positions
0sold out
1famous investor
$0.14avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Sunshine Biopharma Inc. -27 (SBFMW) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were UBS Group AG ($3K), Citadel Advisors ($2K) and Clear Street Group Inc. ($14). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Sunshine Biopharma Inc. -27
- CUSIP
- 867781502
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 9,507 shares sold, net −9,507 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| UBS Group AG | — | Reduce -4.7% | 23,404 | $3K |
| Citadel Advisors | — | Reduce -40.9% | 12,073 | $2K |
| Clear Street Group Inc. | — | — | 94 | $14 |
"% of holder's portfolio" is SBFMW's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. -27 the manager owns.